King Wealth Management Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$332K	Hold	6,000	–	–	0.05%	123
2025 Q1	$290K	Hold	6,000	–	–	0.04%	126
2024 Q4	$232K	Hold	6,000	–	–	0.03%	137
2024 Q3	$270K	Sell	6,000 -6,000	-50%	-$270K	0.04%	119
2024 Q2	$416K	Hold	12,000	–	–	0.07%	95
2024 Q1	$347K	Hold	12,000	–	–	0.06%	104
2023 Q4	$275K	Hold	12,000	–	–	0.05%	112
2023 Q3	$200K	Hold	12,000	–	–	0.04%	136
2023 Q2	$331K	Hold	12,000	–	–	0.07%	106
2023 Q1	$276K	Sell	12,000 -10,000	-45%	-$230K	0.06%	121
2022 Q4	$240K	Hold	22,000	–	–	0.06%	121
2022 Q3	$185K	Hold	22,000	–	–	0.05%	141
2022 Q2	$174K	Hold	22,000	–	–	0.04%	150
2022 Q1	$521K	Hold	22,000	–	–	0.1%	88
2021 Q4	$752K	Hold	22,000	–	–	0.14%	76
2021 Q3	$390K	Hold	22,000	–	–	0.08%	112
2021 Q2	$987K	Hold	22,000	–	–	0.2%	69
2021 Q1	$570K	Hold	22,000	–	–	0.13%	84
2020 Q4	$444K	Hold	22,000	–	–	0.1%	97
2020 Q3	$430K	Hold	22,000	–	–	0.11%	95
2020 Q2	$389K	Hold	22,000	–	–	0.11%	93
2020 Q1	$155K	Hold	22,000	–	–	0.07%	130
2019 Q4	$155K	Buy	22,000 +5,000	+29%	+$35.2K	0.04%	139
2019 Q3	$204K	Hold	17,000	–	–	0.06%	135
2019 Q2	$206K	Sell	17,000 -2,500	-13%	-$30.3K	0.06%	130
2019 Q1	$245K	Sell	19,500 -9,500	-33%	-$119K	0.08%	116
2018 Q4	$195K	Buy	+29,000	New	+$195K	0.07%	119